EUCTR2004-001205-99-IT进行中（未招募）不适用
AN OPEN, MULTICENTRE, RANDOMISED, PARALLEL GROUP STUDY TO COMPARE IN MARGINAL OLD-FOR-OLD RENAL TRANSPLANT PATIENTS THE SAFETY AND EFFICACY OF TWO TREATMENTS:SEQUENTIAL MYCOPHENOLATE MOFETIL / DELAYED TACROLIMUS PLUS STEROIDS VS TACROLIMUS PLUS MYCOPHENOLATE MOFETILIN PATIENTS REQUIRING INDUCTION WITH ANTI-IL2 MONOCLONAL ANTIBODY
FUJISAWA0 个研究点开始时间: 2005年1月12日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
AN OPEN, MULTICENTRE, RANDOMISED PARALLEL GROUP CLINICAL STUDY TO COMPARE SAFETY AND EFFICACY OF TACROLIMUS FK506 WITH MONOCLONAL ANTI-IL2R ANTIBODIES DACLIZUMAB VS TACROLIMUS FK506 WITH STEROIDS AND EVALUATE PHARMACOKINETICS IN LIVER ALLOGRAFT RECIPIENTS RECEIVING SUBOPTIMAL LIVERS.PREVENTION OF REJECTION OF SUBOPTIMAL LIVERS IN LIVER ALLOGRAFT RECIPIENTS. COMPARE SAFETY AND EFFICACY OF TACROLIMUS FK506 WITH MONOCLONAL ANTI-IL2R ANTIBODIES DACLIZUMAB VS TACROLIMUS FK506 WITH STEROIDS AND EVALUATE PHARMACOKINETICS IN LIVER ALLOGRAFT RECIPIENTS RECEIVING SUBOPTIMAL LIVERS.MedDRA version: 9.1Level: HLGTClassification code 10019654Term: Hepatic and hepatobiliary disordersEUCTR2004-002924-16-ITFUJISAWA
进行中（未招募）
不适用
An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiFormTM pMDI compared with Fluticasone pMDI plus Formoterol DPI in adolescent and adult subjects with mild to moderate-severe persistent, reversible asthma. - FLAIR studieAsthma bronchial.MedDRA version: 9.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2007-001634-13-BEMundipharma Research Ltd.200
进行中（未招募）
不适用
An open, randomised, parallel group, multicentre study to compare the efficacyand safety of FlutiForm pMDI vs Seretide pMDI in paediatric subjects withmild to moderate persistent, reversible asthma.Asthma bronchialMedDRA version: 8.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2006-005928-16-DEMundipharma Research Ltd.200
进行中（未招募）
不适用
An open, randomised, parallel group, multicentre study to compare the efficacyand safety of FlutiForm pMDI vs Seretide pMDI in paediatric subjects withmild to moderate persistent, reversible asthma.Asthma bronchialMedDRA version: 8.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2006-005928-16-CZMundipharma Research Ltd.200
进行中（未招募）
不适用
An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiFormTM pMDI vs Fluticasone pMDI plus Formoterol DPI in adolescent and adult subjects with mild to moderate-severe persistent, reversible asthma.Asthma bronchial.MedDRA version: 9.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2007-001634-13-DEMundipharma Research Limited200